Roundtable Discussion; The Future of Mineral Sands. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGenedrive Share News (GDR)

Share Price Information for Genedrive (GDR)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 4.375
Bid: 4.25
Ask: 4.50
Change: -0.025 (-0.57%)
Spread: 0.25 (5.882%)
Open: 4.625
High: 4.625
Low: 4.25
Prev. Close: 4.40
GDR Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

TRADING UPDATES: RTW plans buyback; Octopus AIM VCTs eye fundraise

Wed, 05th Jul 2023 15:30

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Wednesday and not separately reported by Alliance News:

----------

RTW Biotech Opportunities Ltd - investment company focused on the life sciences sector - Says proceeds from Prometheus Biosciences sale total USD99.1 million. Says will retain "appropriate level" of proceeds for new investments. RTW adds: "With the biotech sector only just recovering from the second deepest and second longest bear market in its history, the board consider now to be an opportune time to take receipt of such gains. Valuations are attractive, fundamentals have turned around with the maturation of some modalities and companies, and M&A has become a significant tailwind." RTW also plans share buyback of up to USD10 million. Says current share price "undervalues" firm. Merck & Co in April announced deal to acquire Prometheus for nearly USD11 billion.

----------

Octopus AIM VCT PLC, Octopus AIM VCT 2 PLC - venture capital trusts - The duo plan to launch a new subscription offer later this year. Will announce further details "in due course".

----------

Mineral & Financial Investments Ltd - investment company focused on natural resources sector - Joint-venture partner Ascendant Resources Inc receives expression of interest from UK Export Finance to support a possible credit facility for Lagoa Salgada project in Portugal. Would provide support for up to USD190 million for project, which would represent 70% of total capital expenditure. Mineral & Financial owns 50% of the asset. UKEF is the UK government's credit export agency.

----------

Quantum Exponential Group PLC - London-based quantum technology investor - Invests GBP300,000 as part of wider GBP1.5 million pre-seed funding round in Delta g Ltd. Delta is a gravity sensing hardware and technology development firm. Quantum adds: "The funding round was led by Science Creates Ventures, with additional investment from Newable Ventures, Bristol Private Equity Club and angel investors. This is Quantum Exponential's seventh portfolio company."

----------

Kazera Global PLC - mining-focused investment company - African Mineral Sands Pte Ltd Singapore buys another tranche of Kazera shares from another existing shareholder at 1.5 pence each. It means African Mineral now owns 60.0 million Kazera shares, a 6.4% stake. "AMS and its associated partners have extensive experience in mining and infrastructure projects in Southern Africa and the company believes the addition of AMS as a strategic investor is a positive development, which will provide Kazera with new opportunities for growth and development. AMS and its partners have been investors and offtake partners in the HMS business over the past five years," Kazera explains. Meanwhile, company says pilot plant at Whale Head Minerals is delivering "very promising" heavy mineral sand results. Kazera adds: "HMS samples indicate presence of higher value minerals including rutile, zircon, and monazite. Samples identified to have raised levels of radioactivity and the company has engaged with the national nuclear regulator to determine whether any specific permitting is required."

----------

Zenith Energy Ltd - Africa, Middle East and Europe-focused energy production and development company - Acquires portfolio of mineral leases and oil and gas wells in Texas from Beam Earth Group Ltd. Will fork out USD1.0 million in total. Zenith adds that 60% of that is payable in cash and the remaining 40% in shares. "The acquisition comprises of 155 oil and gas wells located in the vicinity of Midland across licences named Corsicana, Powell, BrookLaw and Sun Valley," Zenith adds. It adds that 47 wells are currently active with a daily production of approximately 60 barrels of oil per day.

----------

Genedrive PLC - Manchester, England-based point-of-care molecular diagnostics company - Announces schedules GBP300,000 drawdown under GBP5 million facility with Riverfort Global Opportunities PCC Ltd. Riverfort Global granted 724,997 warrants, with an exercise price of 23.17 pence.

----------

By Eric Cunha, Alliance News news editor

Comments and questions to newsroom@alliancenews.com

Copyright 2023 Alliance News Ltd. All Rights Reserved.

More News
24 Apr 2024 17:26

Genedrive enters clinical trial deal in US for MT-RNR1 US approval

(Alliance News) - Genedrive PLC on Wednesday said it has entered into a clinical trial agreement to support clinical studies to progress the regulatory approval of its MT-RNR1 product.

Read more
3 Apr 2024 16:54

LONDON MARKET CLOSE: FTSE 100 up thanks to US economic data

(Alliance News) - Stock prices in London closed mostly higher on Wednesday, after some data from the US reinforced the interest rate cut trajectory across the Atlantic.

Read more
3 Apr 2024 13:54

Genedrive shares jump on NICE test recommendation

(Sharecast News) - Genedrive shares were surging on Wednesday, after it received a significant endorsement from the UK's National Institute for Health and Care Excellence (NICE) regarding its 'CYP2C19-ID' test.

Read more
3 Apr 2024 11:49

Genedrive shares surge as UK's NICE backs test for ischaemic stroke

(Alliance News) - Genedrive PLC on Wednesday praised the National Health Service's work on strokes and mini strokes as a test by the company received a recommendation from the UK's National Institute for Health & Care Excellence.

Read more
3 Apr 2024 10:47

AIM WINNERS & LOSERS: UK NICE backs Genedrive test; Corero renews deal

(Alliance News) - The following stocks are the leading risers and fallers on AIM in London on Wednesday.

Read more
28 Mar 2024 14:35

EARNINGS AND TRADING: 888 advances US exit; Arrow ups reserve estimate

(Alliance News) - The following is a round-up of earnings and trading updates by London-listed companies, issued on Wednesday and not separately reported by Alliance News:

Read more
15 Mar 2024 14:27

Genedrive receives R&D tax credit, plans fundraise

(Sharecast News) - Point-of-care pharmacogenetic testing company Genedrive announced the receipt of a research and development tax credit totalling £0.8m on Friday, taking its unaudited cash balances to £1.2m.

Read more
15 Mar 2024 13:50

Genedrive down as plans equity raise despite GBP800,000 tax credit

(Alliance News) - Genedrive PLC shares fell on Friday, after it said it has received a GBP800,000 research and development tax credit.

Read more
19 Feb 2024 18:57

TRADING UPDATES: Coro seals sale terms, Powerhouse makes good progress

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Monday and not separately reported by Alliance News:

Read more
19 Feb 2024 10:56

Genedrive set to apply for NICE EVA funding

(Sharecast News) - Genedrive shares rose on Monday, on the launch of the NICE early value assessment (EVA) evidence generation funding call, backed by the National Institute for Health and Care Research (NIHR).

Read more
19 Feb 2024 07:49

LONDON BRIEFING: MoneySupermarket credits Insurance for growth in 2023

(Alliance News) - Stocks in London are set to fall at Monday's open, as concerns over US inflation trends curb risk appetite, and damp hopes of interest rate cuts from the Federal Reserve.

Read more
2 Jan 2024 14:39

Genedrive confirms £0.6m equity prepayment drawdown

(Sharecast News) - Genedrive confirmed a planned £0.6m drawdown as part of its £5m equity prepayment facility on Tuesday, which it initially disclosed on 31 March 2023.

Read more
2 Jan 2024 10:57

IN BRIEF: Genedrive draws down GBP600,000 on prepayment facility

Genedrive PLC - Manchester, England-based molecular diagnostics company - Draws down GBP600,000 on its GBP5 million equity prepayment facility. In March last year, Genedrive agreed the GBP5 million equity prepayment facility with Riverfort Global Opportunities PCC Ltd. At the time it said that proceeds would be used towards the commercialisation of the antibiotic-induced hearing loss test, Genedrive MT-RNR1 ID Kit, and enhancing the Genedrive platform as well as providing additional working capital.

Read more
22 Dec 2023 15:50

UK shareholder meetings calendar - next 7 days

Monday 25 December 
no events scheduled 
Tuesday 26 December 
no events scheduled 
Wednesday 27 December 
Tremor International LtdAGM
Thursday 28 December 
ADVFN PLCAGM
Altona Rare Earths PLCAGM
Beximco Pharmaceuticals LtdAGM
Global Petroleum LtdAGM
Visum Technologies PLCAGM
Friday 29 December 
Apollon Formularies PLCAGM
Eco Atlantic Oil & Gas LtdAGM
Genedrive PLCAGM
Goldplat PLCAGM
Lansdowne Oil & Gas PLCGM re capital raise
Marula Mining PLCAGM
Microsaic Systems PLCGM re fundraise
Online Blockchain PLCAGM
Secure Property Development & Investment PLCAGM
SkinBioTherapeutics PLCAGM
Tetragon Financial Group LtdAGM
Woodbois LtdAGM
Zambeef Products PLCAGM
  
Copyright 2023 Alliance News Ltd. All Rights Reserved. 

Read more
20 Dec 2023 13:57

Genedrive gets first product orders from several countries

(Sharecast News) - Point-of-care pharmacogenetic testing company Genedrive has received its first orders for Genedrive MT-RNR1 products from several countries, it announced on Wednesday, including France, Austria, Greece, Saudi Arabia, Turkey, and the Netherlands.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.